AbbVie stock pre-market at EUR 253.00

Published on 10/16/2026 at 08:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

AbbVie stock is at EUR 253.00 pre-market at Lang & Schwarz on October 16, 2026, at 8:15 a.m. CEST. AbbVie has scheduled its third-quarter results for October 30, 2026.

Upcoming date and trading quote

AbbVie is scheduled to report third-quarter 2026 results on October 30, 2026.
AbbVie stock trades pre-market at EUR 253.00 at 8:15 a.m. CEST at Lang & Schwarz on October 16, 2026.
The Lang & Schwarz bid was EUR 252.40 and the ask was EUR 253.60 at 8:15 a.m. CEST on October 16, 2026.

Schwarz-Weiß-Reportagefoto einer Wissenschaftlerin am Mikroskop mit dramatischem Seitenlicht — AbbVie Inc. US00287Y1091 Schwarz Weiß Reportage Wissenschaftlerin konzentriert am Mikroskop im sterilen Labor, Illustration mit AI erstellt.

AbbVie stock is at EUR 253.00 in pre-market trading at Lang & Schwarz on October 16, 2026, at 8:15 a.m. CEST. AbbVie has scheduled its third-quarter 2026 financial-results announcement for October 30, 2026, before the market opens, according to an AbbVie investor-relations release.

Pre-market trading

The Lang & Schwarz bid was EUR 252.40 and the ask was EUR 253.60 at 8:15 a.m. CEST on October 16, 2026. The real-time quote of AbbVie stock is updated continuously.

What matters today

AbbVie is scheduled to report third-quarter 2026 results on October 30, 2026. The earnings conference call is scheduled for 8:00 a.m. Central time on that date. AbbVie’s investor-relations release said the webcast will be available through its website.

Market context: Market report S&P 500.

More news and analysis on AbbVie stock